Characterization of triptolide hydroxylation by cytochrome P450 in human and rat liver microsomes
- 21 November 2008
- journal article
- research article
- Published by Taylor & Francis Ltd in Xenobiotica
- Vol. 38 (12), 1551-1565
- https://doi.org/10.1080/00498250802503359
Abstract
Triptolide, the primary active component of a traditional Chinese medicine Tripterygium wilfordii Hook F, has a wide range of pharmacological activities. In the present study, the metabolism of triptolide by cytochrome P450s was investigated in human and rat liver microsomes. Triptolide was converted to four metabolites (M-1, M-2, M-3, and M-4) in rat liver microsomes and three (M-2, M-3, and M-4) in human liver microsomes. All the products were identified as mono-hydroxylated triptolides by liquid chromatography-mass spectrometry (LC-MS). The studies with chemical selective inhibitors, complementary DNA-expressed human cytochrome P450s, correlation analysis, and enzyme kinetics were also conducted. The results demonstrate that CYP3A4 and CYP2C19 could be involved in the metabolism of triptolide in human liver, and that CYP3A4 was the primary isoform responsible for its hydroxylation.Keywords
This publication has 17 references indexed in Scilit:
- Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordiiPhytochemistry, 2007
- Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cellsBlood, 2006
- Ginsenoside Metabolites, Rather Than Naturally Occurring Ginsenosides, Lead to Inhibition of Human Cytochrome P450 EnzymesToxicological Sciences, 2006
- Cytochrome P450s and other enzymes in drug metabolism and toxicityThe AAPS Journal, 2006
- Influence of Ginsenoside Rh1and F1on Human Cytochrome P450 EnzymesPlanta Medica, 2006
- Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. III. Suppression of graft-versus-host disease in murine allogeneic bone marrow transplantation by the PG27 extractTransplantation, 2002
- Triptolide, A Novel Immunosuppressive and Anti-Inflammatory Agent Purified from a Chinese Herb Tripterygium Wilfordii Hook FLeukemia & Lymphoma, 2001
- Characterization of CYP2C19 and CYP2C9 from Human Liver: Respective Roles in Microsomal Tolbutamide,S-Mephenytoin, and Omeprazole HydroxylationsArchives of Biochemistry and Biophysics, 1998
- Isolation, purification, and characterization of immunosuppressive compounds from tripterygium: Triptolide and tripdiolideInternational Journal of Immunopharmacology, 1995
- Utility of in vitro drug metabolism data in predicting in vivo metabolic clearanceBiochemical Pharmacology, 1994